Glucagon-Like Peptide-2 Increases Intestinal Lipid Absorption and Chylomicron Production via CD36

Gastroenterology

Volumn 137, Issue 3, 2009, Pages

  Hsieh, Joanne ^a,b   Longuet, Christine ^c   Maida, Adriano ^c   Bahrami, Jasmine ^c   Xu, Elaine ^a   Baker, Christopher L ^a   Brubaker, Patricia L ^b   Drucker, Daniel J ^c   Adeli, Khosrow ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B48; CD36 ANTIGEN; CHOLESTEROL; CHYLOMICRON; FATTY ACID; FATTY ACID TRANSPORTER; GLUCAGON LIKE PEPTIDE 2; OLIVE OIL; TRIOLEIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FAST PROTEIN LIQUID CHROMATOGRAPHY; GLYCOSYLATION; HAMSTER; IMMUNOBLOTTING; INTESTINE ABSORPTION; JEJUNUM; LIPID ABSORPTION; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SYNTHESIS;

EID: 69249095458     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.05.051     Document Type: Article

References (39)

1. Boquist S., Ruotolo G., Tang R., et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 100 (1999) 723-728
2. Nakano T., Nakajima K., Niimi M., et al. Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases. Clin Chim Acta 390 (2008) 38-43
3. Taskinen M.R. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 46 (2003) 733-749
4. Gylling H., Tuominen J.A., Koivisto V.A., et al. Cholesterol metabolism in type 1 diabetes. Diabetes 53 (2004) 2217-2222
5. Hussain M.M. A proposed model for the assembly of chylomicrons. Atherosclerosis 148 (2000) 1-15
6. Guo Q., Avramoglu R.K., and Adeli K. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids. Metabolism 54 (2005) 689-697
7. Federico L.M., Naples M., Taylor D., et al. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine. Diabetes 55 (2006) 1316-1326
8. Haidari M., Leung N., Mahbub F., et al. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem 277 (2002) 31646-31655
9. Zoltowska M., Ziv E., Delvin E., et al. Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes 52 (2003) 2539-2545
10. Estall J.L., and Drucker D.J. Glucagon-like peptide-2. Annu Rev Nutr 26 (2006) 391-411
11. Yusta B., Huang L., Munroe D., et al. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119 (2000) 744-755
12. Guan X., Karpen H.E., Stephens J., et al. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 130 (2006) 150-164
13. Orskov C., Hartmann B., Poulsen S.S., et al. GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept 124 (2005) 105-112
14. Tang-Christensen M., Larsen P.J., Thulesen J., et al. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med 6 (2000) 802-807
15. Koehler J.A., Yusta B., and Drucker D.J. The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways. Mol Endocrinol 19 (2005) 459-473
16. Dube P.E., Forse C.L., Bahrami J., et al. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology 131 (2006) 589-605
17. Cheeseman C.I. Up-regulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol 273 (1997) R1965-R1971
18. Au A., Gupta A., Schembri P., et al. Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2. Biochem J 367 (2002) 247-254
19. Rocca A.S., LaGreca J., Kalitsky J., et al. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology 142 (2001) 1148-1155
20. Meier J.J., Nauck M.A., Pott A., et al. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 130 (2006) 44-54
21. Qin B., Qiu W., Avramoglu R.K., et al. Tumor necrosis factor-α induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins. Diabetes 56 (2007) 450-461
22. Nassir F., Wilson B., Han X., et al. CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine. J Biol Chem 282 (2007) 19493-19501
23. Brubaker P.L., Izzo A., Hill M., et al. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol 272 (1997) E1050-E1058
24. Pedersen N.B., Hjollund K.R., Johnsen A.H., et al. Porcine glucagon-like peptide-2: structure, signaling, metabolism and effects. Regul Pept 146 (2008) 310-320
25. Stahl A., Hirsch D.J., Gimeno R.E., et al. Identification of the major intestinal fatty acid transport protein. Mol Cell 4 (1999) 299-308
26. Milger K., Herrmann T., Becker C., et al. Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4. J Cell Sci 119 (2006) 4678-4688
27. Drover V.A., Ajmal M., Nassir F., et al. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J Clin Invest 115 (2005) 1290-1297
28. Nauli A.M., Nassir F., Zheng S., et al. CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. Gastroenterology 131 (2006) 1197-1207
29. Eyre N.S., Cleland L.G., Tandon N.N., et al. Importance of the carboxyl terminus of FAT/CD36 for plasma membrane localization and function in long-chain fatty acid uptake. J Lipid Res 48 (2007) 528-542
30. Luiken J.J., Koonen D.P., Willems J., et al. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51 (2002) 3113-3119
31. Febbraio M., Abumrad N.A., Hajjar D.P., et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274 (1999) 19055-19062
32. Goudriaan J.R., den Boer M.A., Rensen P.C., et al. CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance. J Lipid Res 46 (2005) 2175-2181
33. Densupsoontorn N., Carpentier Y.A., Racine R., et al. CD36 and proteoglycan-mediated pathways for (n-3) fatty acid enriched triglyceride-rich particle blood clearance in mouse models in vivo and in peritoneal macrophages in vitro. J Nutr 138 (2008) 257-261
34. Pohl J., Ring A., Korkmaz U., et al. FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts. Mol Biol Cell 16 (2005) 24-31
35. Levy E., Stan S., Delvin E., et al. Localization of microsomal triglyceride transfer protein in the Golgi: possible role in the assembly of chylomicrons. J Biol Chem 277 (2002) 16470-16477
36. Amato A., Baldassano S., Serio R., et al. Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release. Am J Physiol Gastrointest Liver Physiol 296 (2009) G678-G684
37. Bozkurt A., Naslund E., Holst J.J., et al. GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat. Regul Pept 107 (2002) 129-135
38. Fischer K.D., Dhanvantari S., Drucker D.J., et al. Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats. Am J Physiol 273 (1997) E815-E820
39. Gleeson A., Anderton K., Owens D., et al. The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 42 (1999) 944-948